- Home
- NXC vs PETS Comparison
NXC vs PETS Comparison
Compare NXC & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXC
- PETS
- Stock Information
- Founded
- NXC 1992
- PETS 1996
- Country
- NXC United States
- PETS United States
- Employees
- NXC N/A
- PETS N/A
- Industry
- NXC Investment Managers
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- NXC Finance
- PETS Consumer Staples
- Exchange
- NXC Nasdaq
- PETS Nasdaq
- Market Cap
- NXC 83.5M
- PETS 58.9M
- IPO Year
- NXC N/A
- PETS N/A
- Fundamental
- Price
- NXC $13.01
- PETS $2.82
- Analyst Decision
- NXC
- PETS Sell
- Analyst Count
- NXC 0
- PETS 1
- Target Price
- NXC N/A
- PETS $3.20
- AVG Volume (30 Days)
- NXC 17.5K
- PETS 92.2K
- Earning Date
- NXC 01-01-0001
- PETS 11-05-2025
- Dividend Yield
- NXC 3.97%
- PETS N/A
- EPS Growth
- NXC N/A
- PETS N/A
- EPS
- NXC 0.19
- PETS 0.02
- Revenue
- NXC N/A
- PETS $247,010,000.00
- Revenue This Year
- NXC N/A
- PETS N/A
- Revenue Next Year
- NXC N/A
- PETS N/A
- P/E Ratio
- NXC $70.47
- PETS $164.97
- Revenue Growth
- NXC N/A
- PETS N/A
- 52 Week Low
- NXC $11.86
- PETS $2.72
- 52 Week High
- NXC $13.70
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- NXC 52.06
- PETS 50.01
- Support Level
- NXC N/A
- PETS N/A
- Resistance Level
- NXC $13.05
- PETS $3.08
- Average True Range (ATR)
- NXC 0.09
- PETS 0.10
- MACD
- NXC -0.46
- PETS -0.12
- Stochastic Oscillator
- NXC 99.69
- PETS 88.68
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing in municipal obligations.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.